FEB 04, 2019 3:49 PM PST

Can Chemotherapy Be Improved?

WRITTEN BY: Amy Loriaux

With all of these "new and improved" methods to treat cancer, such as immunotherapy, nanotechnology, and genetic-based personalized treatment, where does chemotherapy (chemo) stand now? Is it going the way of mercury treatments, or does it still have some use? Are researchers even trying to optimize chemo anymore? Well, it turns out that there are some researchers working on ways to improve chemo, as it is still the first course of treatment for many. A 2015 book published by Expanded Academic ASAP, Future Oncologyincludes a chapter written by Dr. Thomas Mehrling of Mundipharma EDO GmbH, Basel, Switzerland, called "Chemotherapy is getting 'smarter'" details the advancements made in chemotherapy in the last decade.

Photo source: Adobe Shutterstock (with permission)

In this chapter, Dr. Mehrling describes exactly how chemo is getting "smarter". It is doing so by specifically targeting and killing tumor cells without affecting healthy cells. This represents a giant step forward in cancer treatment, with novel chemo drugs being able to tell the difference between tumor cells and normal cells. This is a pretty advanced step from the usual regimen such as CHOP (cyclophosphamide, hydroxydaunomycin, vincristine, and prednisolone) for lymphoma, melphalan-prednisone for multiple myeloma or platinum-based therapy for lung cancer. These were your typical treatment options. Unfortunately, mortality rates remained high.

Previous attempts to tweak chemo treatment included "high dose chemotherapy", where escalating doses of drugs are administered over time to decrease the likelihood of developing drug resistance. However, this method has extremely adverse side effects due to toxicity. In fact, toxicity is the most significant issue in the use of high-dose chemo which could require prolonged hospitalization. Furthermore, and most importantly, this form of chemo treatment has not led to decreases in mortality rates.

Cancer treatment is becoming more and more targeted, chemo included. In recent years, new targeted therapies have emerged, including immunotherapy. The combination of new targeted therapies and existing chemo has resulted in considerable improvement in outcomes. Some clinicians believe that treatment with chemo could become redundant. Nevertheless, scientists followed-up on these improved prognoses and started to develop similar drugs, ones with an improved risk/benefit profile.

Photo source: Pexels.com

So where is chemo now? According to Dr. Mehrling, chemo "now finds itself at crossroads". According to him, chemo is about to evolve, more effectively targeting tumor cells while ignoring healthy cells. There are emerging trends, such as immunotherapy and cytotoxic therapy using nanotechnology. Chemo is now considered as an adjunct therapy and is used primarily for certain cancers that need targeted cytotoxic treatment.

For example, those very highly toxic chemotherapies, too toxic to give alone, could be given at a reduced dose alongside a tumor-specific antibody. This combination treatment has resulted in significantly improved outcomes for patients, especially for Hodgkin's lymphoma. These encouraging results translated into drugs which quickly made their way to the market through accelerated regulatory pathways for potential life-saving therapies.

So, for now, chemo is not going away. Instead, it is being used alongside groundbreaking discoveries and novel treatment methods. Chemo drugs have been used primarily for their overall toxicity. They are great drugs for killing rapidly growing cells. However, historically they killed any fast-growing cells, leading to very harsh side effects. This is Dr. Mehrling's basic point: drugs that can differentiate "good" from "cancer" cells can have tremendous therapeutic potential. These drugs are indeed getting "smarter".

Sources: jmvh.org, www.cancer.orgFuture Oncology, Pharmacy & Therapeutics, Drugs, www.News-Medical.net

About the Author
  • I currently work at a small CRO involved in clinical trial management.
You May Also Like
JUN 22, 2020
Cancer
Methylation Markers That Can be Used to Diagnose Pancreatic Cancer
JUN 22, 2020
Methylation Markers That Can be Used to Diagnose Pancreatic Cancer
Diagnostic tests are the unsung heroes of cancer treatment. While there are more treatments for cancer coming out every ...
JUL 01, 2020
Cancer
Surgeons use glowing dye in dogs to improve mammary cancer excision practices
JUL 01, 2020
Surgeons use glowing dye in dogs to improve mammary cancer excision practices
A glowing dye could help surgeons leave better “clean margins” during cancer excisions, allowing them to mak ...
JUL 11, 2020
Cancer
New drug combo could improve immunotherapy for SCCOHT ovarian cancer
JUL 11, 2020
New drug combo could improve immunotherapy for SCCOHT ovarian cancer
Research published recently in PLOS ONE reports on SP-2577, a drug that could help girls and young women plagued with a ...
JUL 19, 2020
Drug Discovery & Development
Nanodrug for Treating Invasive Breast Cancer
JUL 19, 2020
Nanodrug for Treating Invasive Breast Cancer
Scientists at the University of Arkansas created a nano-drug that may eradicate triple-negative breast cancer cells. Fin ...
JUL 22, 2020
Cancer
Immunotherapy: the risk for cancer patients with COVID-19
JUL 22, 2020
Immunotherapy: the risk for cancer patients with COVID-19
Research presented at the American Association for Cancer Research Virtual Meeting: COVID-19 and Cancer earlier this wee ...
AUG 11, 2020
Immunology
Study Reveals the Two Sides of an Immune Molecule
AUG 11, 2020
Study Reveals the Two Sides of an Immune Molecule
Scientists have discovered a key protein that regulates the immune system to fight off infections. Fascinatingly, the pr ...
Loading Comments...